Back to B. Metzler seel. Sohn & Co. AG B. Metzler seel. Sohn & Co. AG

BBIOBBIO

Showing 9 of 19 quarters

Position history for B. Metzler seel. Sohn & Co. AGB. Metzler seel. Sohn & Co. AG's holdings in BridgeBio Pharma, Inc.

Yes. B. Metzler seel. Sohn holds 17,506 shares of BBIO (BridgeBio Pharma), worth $1.2M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. B. Metzler seel. Sohn has held BBIO since Q1 2022, across 19 quarterly 13F filings.

Current Value

$1.2M

Current Shares

17,506

Total Value Change

+$219,983

Total Shares Change

-19,097

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
17,506
0.0%
$1.2M0.0%$65.80
0
2026-Q2
Unchanged
17,506
0.0%
$1.3M0.0%$74.48
0
2026-Q1
Unchanged
17,506
0.0%
$1.3M0.0%$74.26
0
2025-Q4
Decreased
17,506
-29.3%
$1.3M0.0%$76.49
0
2025-Q3
Decreased
24,751
-32.4%
$1.3M0.0%$51.94
0
2025-Q2
Unchanged
36,603
0.0%
$1.6M0.0%$43.18
0
2025-Q1
Unchanged
36,603
0.0%
$1.3M0.0%$34.57
0
2024-Q4
Unchanged
36,603
0.0%
$1M0.0%$27.44
0
2024-Q3
Increased
36,603
+25.8%
$931,9120.0%$25.46
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used